Q3 2025 Syngene International Ltd Earnings Call Transcript
Key Points
- Syngene International Ltd (BOM:539268) reported a revenue increase of 11% year-on-year for the third quarter, indicating a return to growth.
- Operating EBITDA rose by 23% to INR284 crores, with margins improving by 300 basis points to 30.1%.
- The company benefited from a favorable exchange rate, contributing to an 8% increase in revenue from operations in constant currency terms.
- Discovery services showed growth, with successful conversions of pilot projects into long-term contracts.
- Syngene maintained a strong balance sheet with a net cash position of INR838 crores as of December 2024, supporting future investments and growth.
- The US biotech funding environment stabilized slower than anticipated, impacting the timing of revenue growth.
- Revenue guidance was revised downwards from high single-digit to mid-single-digit growth, reflecting a delay in market recovery.
- Staff costs increased by 14% year-on-year due to salary increments and recruitment, impacting overall profitability.
- Operating costs rose by 18% year-on-year, driven by investments in digital initiatives and maintenance of expanded facilities.
- The company faced a decline in revenue and EBITDA in the first half of the year, offsetting the recovery seen in the third quarter.
Ladies and gentlemen, good day and welcome to Syngene International's third quarter FY 2025 financial results conference call. (Operator Instructions). Note that this conference is being recorded. I now hand the conference over to Ms. Nandini Agarwal. Thank you and over to you.
Good evening, everyone. Thank you for joining us on this call to discuss Syngene's third quarter and nine-month results for FY 2025. To discuss the financial and business performance for the period, we have on this call today, Mr Jonathan Hunt, Syngene's Managing Director and Chief Executive Officer and Mr. Deepak Jain, Chief Financial Officer.
After the opening remarks, Jonathan and Deepak will be happy to answer any questions you may have. Before we begin, I would like to caution that comments made during this conference call today will contain certain forward-looking statements and must be viewed in relation to the risks pertaining to the business.
The safe harbor clause indicated in the investor
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
